Article |
SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes
1Intramural Research Support Program, SAIC-Frederick, NCI-FCRDC Frederick, MD, USA 2Division of Cancer Epidemiology and Genetics, National Cancer Institute Bethesda, MD, USA 3Department of Bioinformatics, George Mason University Manassas, VA, USA 4Office of Cancer Genomics, National Cancer Institute Bethesda, MD, USA 5Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health Gaithersburg, MD, USA
*To whom correspondence should be addressed. Tel: +1 301 496 6019; Fax: +1 301 402 3134; Email: packerb{at}mail.nih.gov
Received September 14, 2005. Revised October 28, 2005. Accepted October 28, 2005.
The SNP500Cancer database provides sequence and genotype assay information for candidate SNPs useful in mapping complex diseases, such as cancer. The database is an integral component of the NCI Cancer Genome Anatomy Project (http://cgap.nci.nih.gov). SNP500Cancer reports sequence analysis of anonymized control DNA samples (n = 102 Coriell samples representing four self-described ethnic groups: African/African-American, Caucasian, Hispanic and Pacific Rim). The website is searchable by gene, chromosome, gene ontology pathway, dbSNP ID and SNP500Cancer SNP ID. As of October 2005, the database contains >13 400 SNPs, 9124 of which have been sequenced in the SNP500Cancer population. For each analysed SNP, gene location and >200 bp of surrounding annotated sequence (including nearby SNPs) are provided, with frequency information in total and per subpopulation as well as calculation of HardyWeinberg equilibrium for each subpopulation. The website provides the conditions for validated sequencing and genotyping assays, as well as genotype results for the 102 samples, in both viewable and downloadable formats. A subset of sequence validated SNPs with minor allele frequency >5% are entered into a high-throughput pipeline for genotyping analysis to determine concordance for the same 102 samples. In addition, the results of genotype analysis for select validated SNP assays (defined as 100% concordance between sequence analysis and genotype results) are posted for an additional 280 samples drawn from the Human Diversity Panel (HDP). SNP500Cancer provides an invaluable resource for investigators to select SNPs for analysis, design genotyping assays using validated sequence data, choose selected assays already validated on one or more genotyping platforms, and select reference standards for genotyping assays. The SNP500Cancer database is freely accessible via the web page at http://snp500cancer.nci.nih.gov.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. E. Moore, P. Brennan, S. Karami, I. Menashe, S. I. Berndt, L. M. Dong, A. Meisner, M. Yeager, S. Chanock, J. Colt, et al. Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk Cancer Res., October 15, 2009; 69(20): 8001 - 8008. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lee, A. K. Park, K.-M. Lee, S. K. Park, S. Han, W. Han, D.-Y. Noh, K.-Y. Yoo, H. Kim, S. J. Chanock, et al. Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women Carcinogenesis, September 1, 2009; 30(9): 1528 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Lagmay, W. B. London, T. G. Gross, A. Termuhlen, N. Sullivan, A. Axel, B. Mundy, M. Ranalli, J. Canner, P. McGrady, et al. Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor) Clin. Cancer Res., August 15, 2009; 15(16): 5234 - 5239. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Hussain, L.-N. Mu, L. Cai, S.-C. Chang, S. L. Park, S. S. Oh, Y. Wang, B. Y. Goldstein, B.-G. Ding, Q. Jiang, et al. Genetic Variation in Immune Regulation and DNA Repair Pathways and Stomach Cancer in China Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2304 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Chen, C. J. Marsit, B. C. Christensen, E.A. Houseman, M. D. McClean, J. F. Smith, J. T. Bryan, M. R. Posner, H. H. Nelson, and K. T. Kelsey Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer Carcinogenesis, June 1, 2009; 30(6): 977 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lou, M. Yeager, H. Li, J. G. Bosquet, R. B. Hayes, N. Orr, K. Yu, A. Hutchinson, K. B. Jacobs, P. Kraft, et al. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility PNAS, May 12, 2009; 106(19): 7933 - 7938. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Han, T. Zheng, Q. Lan, Y. Zhang, B. A. Kilfoy, Q. Qin, N. Rothman, S. H. Zahm, T. R. Holford, B. Leaderer, et al. Genetic Polymorphisms in Nitric Oxide Synthase Genes Modify the Relationship between Vegetable and Fruit Intake and Risk of Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1429 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rezgui, C. Williams, S. A Savage, S. N Prince, O. J Zaccheo, E Y. Jones, M. P Crump, and A B. Hassan Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth J. Mol. Endocrinol., April 1, 2009; 42(4): 341 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang, A. Trentham-Dietz, M. Garcia-Closas, P. A. Newcomb, L. Titus-Ernstoff, J. M. Hampton, S. J. Chanock, J. L. Haines, and K. M. Egan Association of CYP1B1 Haplotypes and Breast Cancer Risk in Caucasian Women Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1321 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morton, M. P. Purdue, T. Zheng, S. S. Wang, B. Armstrong, Y. Zhang, I. Menashe, N. Chatterjee, S. Davis, Q. Lan, et al. Risk of Non-Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1259 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, D. Kang, S. K. Park, S. I. Berndt, D. Reding, N. Chatterjee, S. Chanock, W.-Y. Huang, and R. B. Hayes Nitric oxide synthase gene polymorphisms and prostate cancer risk Carcinogenesis, April 1, 2009; 30(4): 621 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Yang, M. Garcia-Closas, J. V. Lacey Jr., L. A. Brinton, J. Lissowska, B. Peplonska, S. Chanock, and M. M. Gaudet Genetic Variation in the Androgen Receptor Gene and Endometrial Cancer Risk Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 585 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Karchin Next generation tools for the annotation of human SNPs Brief Bioinform, January 1, 2009; 10(1): 35 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lan, L. Zhang, M. Shen, W. J. Jo, R. Vermeulen, G. Li, C. Vulpe, S. Lim, X. Ren, S. M. Rappaport, et al. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity Carcinogenesis, January 1, 2009; 30(1): 50 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Freedman, J. Ahn, L. Hou, J. Lissowska, W. Zatonski, M. Yeager, S. J. Chanock, W. H. Chow, and C. C. Abnet Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer Carcinogenesis, January 1, 2009; 30(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Chang, M. R. Wrensch, H. M. Hansen, J. D. Sison, M. C. Aldrich, C. P. Quesenberry Jr, M. F. Seldin, K. T. Kelsey, and J. K. Wiencke Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans Carcinogenesis, January 1, 2009; 30(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-h. Chang, M. L. Lindegren, M. A. Butler, S. J. Chanock, N. F. Dowling, M. Gallagher, R. Moonesinghe, C. A. Moore, R. M. Ned, M. R. Reichler, et al. Prevalence in the United States of Selected Candidate Gene Variants: Third National Health and Nutrition Examination Survey, 1991-1994 Am. J. Epidemiol., January 1, 2009; 169(1): 54 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morton, S. S. Wang, W. Cozen, M. S. Linet, N. Chatterjee, S. Davis, R. K. Severson, J. S. Colt, M. A. Vasef, N. Rothman, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes Blood, December 15, 2008; 112(13): 5150 - 5160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Johnson, S. Corthals, C. Ramos, A. Hoering, K. Cocks, N. J. Dickens, J. Haessler, H. Goldschmidt, J. A. Child, S. E. Bell, et al. Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping Blood, December 15, 2008; 112(13): 4924 - 4934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gaudet, S. Chanock, A. Dunning, K. Driver, L. A. Brinton, J. Lissowska, B. Peplonska, P. Pharoah, and M. Garcia-Closas HSD17B1 Genetic Variants and Hormone Receptor-Defined Breast Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2766 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Figueroa, N. Malats, M. Garcia-Closas, F. X. Real, D. Silverman, M. Kogevinas, S. Chanock, R. Welch, M. Dosemeci, Q. Lan, et al. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes Carcinogenesis, October 1, 2008; 29(10): 1955 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mahajan, E. M. El-Omar, J. Lissowska, P. Grillo, C. S. Rabkin, A. Baccarelli, M. Yeager, L. H. Sobin, W. Zatonski, S. J. Channock, et al. Genetic Variants in T Helper Cell Type 1, 2 and 3 Pathways and Gastric Cancer Risk in a Polish Population Jpn. J. Clin. Oncol., September 1, 2008; 38(9): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, W.-Y. Huang, G. Andreotti, Y.-T. Gao, A. Rashid, J. Chen, L. C. Sakoda, M.-C. Shen, B.-S. Wang, S. Chanock, et al. Variants of DNA Repair Genes and the Risk of Biliary Tract Cancers and Stones: A Population-Based Study in China Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2123 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Hsing, L. C. Sakoda, A. Rashid, G. Andreotti, J. Chen, B.-S. Wang, M.-C. Shen, B. E. Chen, P. S. Rosenberg, M. Zhang, et al. Variants in Inflammation Genes and the Risk of Biliary Tract Cancers and Stones: A Population-Based Study in China Cancer Res., August 1, 2008; 68(15): 6442 - 6452. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Beckett, S. J. Laughton, L. D. Pozza, G. B. McCowage, G. Marshall, R. J. Cohn, E. Milne, and L. J. Ashton Buccal Swabs and Treated Cards: Methodological Considerations for Molecular Epidemiologic Studies Examining Pediatric Populations Am. J. Epidemiol., May 15, 2008; 167(10): 1260 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Chang, A. Rashid, Y.-T. Gao, G. Andreotti, M.-C. Shen, B.-S. Wang, T.-Q. Han, B.-H. Zhang, L. C. Sakoda, M. F. Leitzmann, et al. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China Carcinogenesis, May 1, 2008; 29(5): 944 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brooks, R. E. Shore, A. Zeleniuch-Jacquotte, D. Currie, Y. Afanasyeva, K. L. Koenig, A. A. Arslan, P. Toniolo, and I. Wirgin Polymorphisms in RAD51, XRCC2, and XRCC3 Are Not Related to Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 1016 - 1019. [Full Text] [PDF] |
||||
![]() |
V. M. Chia, L. C. Sakoda, B. I. Graubard, M. V. Rubertone, S. J. Chanock, R. L. Erickson, and K. A. McGlynn Risk of Testicular Germ Cell Tumors and Polymorphisms in the Insulin-Like Growth Factor Genes Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 721 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Andreotti, J. Chen, Y.-T. Gao, A. Rashid, B. E. Chen, P. Rosenberg, L. C. Sakoda, J. Deng, M.-C. Shen, B.-S. Wang, et al. Polymorphisms of Genes in the Lipid Metabolism Pathway and Risk of Biliary Tract Cancers and Stones: A Population-Based Case-Control Study in Shanghai, China Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hazra, S. Chanock, E. Giovannucci, D. G. Cox, T. Niu, C. Fuchs, W. C. Willett, and D. J. Hunter Large-Scale Evaluation of Genetic Variants in Candidate Genes for Colorectal Cancer Risk in the Nurses' Health Study and the Health Professionals' Follow-up Study Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rajaraman, A. Hutchinson, N. Rothman, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, M. S. Linet, and P. D. Inskip Oxidative response gene polymorphisms and risk of adult brain tumors Neuro-oncol, January 1, 2008; 10(5): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, F. R. Schumacher, C. A. Haiman, D. O. Stram, D. Albanes, D. Altshuler, G. Berglund, J. Buring, E. E. Calle, F. Clavel-Chapelon, et al. CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2237 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Closas, M. A. Troester, Y. Qi, A. Langerod, M. Yeager, J. Lissowska, L. Brinton, R. Welch, B. Peplonska, D. S. Gerhard, et al. Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor {alpha} Tumor Status Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2269 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Collard, S. K. Shernan, A. A. Fox, T. Bernig, S. J. Chanock, W. K. Vaughn, K. Takahashi, A. B. Ezekowitz, P. Jarolim, and S. C. Body The MBL2 'LYQA Secretor' Haplotype Is an Independent Predictor of Postoperative Myocardial Infarction in Whites Undergoing Coronary Artery Bypass Graft Surgery Circulation, September 11, 2007; 116(11_suppl): I-106 - I-112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rajaraman, S. S. Wang, N. Rothman, M. M. Brown, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, S. J. Chanock, et al. Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Savage, K. Woodson, E. Walk, W. Modi, J. Liao, C. Douglass, R. N. Hoover, S. J. Chanock, and The National Osteosarcoma Etiology Study Group Analysis of Genes Critical for Growth Regulation Identifies Insulin-like Growth Factor 2 Receptor Variations with Possible Functional Significance as Risk Factors for Osteosarcoma Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1667 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kang, K.-M. Lee, S. K. Park, S. I. Berndt, U. Peters, D. Reding, N. Chatterjee, R. Welch, S. Chanock, W.-Y. Huang, et al. Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1581 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Sprague, A. Trentham-Dietz, M. Garcia-Closas, P. A. Newcomb, L. Titus-Ernstoff, J. M. Hampton, S. J. Chanock, J. L. Haines, and K. M. Egan Genetic variation in TP53 and risk of breast cancer in a population-based case control study Carcinogenesis, August 1, 2007; 28(8): 1680 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Michiels, P. Danoy, P. Dessen, A. Bera, T. Boulet, C. Bouchardy, M. Lathrop, A. Sarasin, and S. Benhamou Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers Carcinogenesis, August 1, 2007; 28(8): 1731 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Morton, L. Bernstein, S. S. Wang, D. W. Hein, N. Rothman, J. S. Colt, S. Davis, J. R. Cerhan, R. K. Severson, R. Welch, et al. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma Carcinogenesis, August 1, 2007; 28(8): 1759 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Figueroa, N. Malats, N. Rothman, F. X. Real, D. Silverman, M. Kogevinas, S. Chanock, M. Yeager, R. Welch, M. Dosemeci, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk Carcinogenesis, August 1, 2007; 28(8): 1788 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yu, Z. Li, N. Jolicoeur, L. Zhang, Y. Fortin, E. Wang, M. Wu, and S.-H. Shen Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers Nucleic Acids Res., July 26, 2007; 35(13): 4535 - 4541. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, M. Shen, R. S. Chapman, M. Yeager, R. Welch, X. He, T. Zheng, H. D. Hosgood, D. Yang, S. I. Berndt, et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China Carcinogenesis, July 1, 2007; 28(7): 1437 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Solomou, F. Gibellini, B. Stewart, D. Malide, M. Berg, V. Visconte, S. Green, R. Childs, S. J. Chanock, and N. S. Young Perforin gene mutations in patients with acquired aplastic anemia Blood, June 15, 2007; 109(12): 5234 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kang, K.-M. Lee, S. K. Park, S. I. Berndt, D. Reding, N. Chatterjee, R. Welch, S. Chanock, W.-Y. Huang, and R. B. Hayes Lack of Association of Transforming Growth Factor-{beta}1 Polymorphisms and Haplotypes with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Trial Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1303 - 1305. [Full Text] [PDF] |
||||
![]() |
Q. Lan, T. Zheng, S. Chanock, Y. Zhang, M. Shen, S. S. Wang, S. I. Berndt, S. H. Zahm, T. R. Holford, B. Leaderer, et al. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma Carcinogenesis, April 1, 2007; 28(4): 823 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bernig, B. J. Boersma, T. M. Howe, R. Welch, S. Yadavalli, B. Staats, L. E. Mechanic, S. J. Chanock, and S. Ambs The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women Carcinogenesis, April 1, 2007; 28(4): 828 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lim, S. S. Wang, P. Hartge, W. Cozen, L. E. Kelemen, S. Chanock, S. Davis, A. Blair, M. Schenk, N. Rothman, et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study Blood, April 1, 2007; 109(7): 3050 - 3059. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Purdue, Q. Lan, A. Kricker, A. E. Grulich, C. M. Vajdic, J. Turner, D. Whitby, S. Chanock, N. Rothman, and B. K. Armstrong Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study Carcinogenesis, March 1, 2007; 28(3): 704 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Mechanic, E. D. Bowman, J. A. Welsh, M. A. Khan, N. Hagiwara, L. Enewold, P. G. Shields, L. Burdette, S. Chanock, and C. C. Harris Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Purdue, L. C. Sakoda, B. I. Graubard, R. Welch, S. J. Chanock, I. A. Sesterhenn, M. V. Rubertone, R. L. Erickson, and K. A. McGlynn A Case-Control Investigation of Immune Function Gene Polymorphisms and Risk of Testicular Germ Cell Tumors Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hou, E.M. El-Omar, J. Chen, P. Grillo, C.S. Rabkin, A. Baccarelli, M. Yeager, S.J. Chanock, W. Zatonski, L.H. Sobin, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer Carcinogenesis, January 1, 2007; 28(1): 118 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, H. Liu, Z. Zhang, M. R. Spitz, and Q. Wei Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2364 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hill, S. S. Wang, J. R. Cerhan, S. Davis, W. Cozen, R. K. Severson, P. Hartge, S. Wacholder, M. Yeager, S. J. Chanock, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes Blood, November 1, 2006; 108(9): 3161 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gaudet, S. Chanock, J. Lissowska, S. I. Berndt, B. Peplonska, L. A. Brinton, R. Welch, M. Yeager, A. Bardin-Mikolajczak, and M. Garcia-Closas Comprehensive Assessment of Genetic Variation of Catechol-O-Methyltransferase and Breast Cancer Risk Cancer Res., October 1, 2006; 66(19): 9781 - 9785. [Abstract] [Full Text] [PDF] |
||||












